An assessment of the use of mammography and colonoscopy among fee-for-service Medicare beneficiaries before and after the Affordable Care Act demonstrates the impact of out-of-pocket costs in this population.
Survey data from patients receiving care at Boston Medical Center who were navigated for colonoscopy screening illustrates how patients value the services of oncology patient navigators.
Novel preparation formulation is as effective and safe as current colon prep for colonoscopy. Plus, study participants gave the prep experience a high satisfaction rating.
Screening for colorectal cancer (CRC) is not widely used by Americans age 75 years and older, even though some patients are healthy and may benefit.
Offering free screening colonoscopies can identify CRC earlier in uninsured patients who are at high risk for developing the disease. In addition, the program is cost neutral from the perspective of a hospital system.
The time between a positive fecal blood test result for colon cancer screening and a follow-up colonoscopy varies widely across the United States.
The generally low risk of colonoscopy and the widely accepted guidelines for polyp surveillance and colon cancer screening may render precolonoscopy gastroenterology office visits unnecessary.
Fifteen variables independently associated with measure; shows variation in quality among facilities
A new risk assessment scoring system could help physicians determine which patients can forgo invasive colonoscopy for cancer screening and which patients should undergo the procedure.
Having patients lie on their left side while examining the right side of their colon during a colonoscopy can result in more polyps being found, thus increasing the effectiveness of the screening technique.
A clinical scoring system for colon cancer risk could help physicians determine which patients require colonoscopies and which could be adequately screened using less invasive methods.
Patients with colorectal cancer that is detected during a colonoscopy screening are more likely to survive to longer than patients who are not diagnosed until they have symptoms.
Higher adenoma detection rates may be associated with much lower lifetime colorectal cancer incidence and death without higher overall costs, research indicates.
Higher-quality colonoscopies, which need not be more expensive, are linked to lower colorectal cancer risk.
Higher adenoma detection rates from colonoscopy screenings may be associated with a lower lifetime colorectal cancer incidence.
A new noninvasive technology for colon cancer screening could prove promising for African-Americans, a group at higher than average risk of colon cancer.
In an average-risk screening population, capsule colonoscopy seems adequate for patients who cannot undergo colonoscopy or who had incomplete colonoscopies.
A recent study examined why individuals do not always follow through with colorectal cancer screening.
A new study indicates that raising the colorectal cancer screening rates to 80% by 2018 could prevent an additional 21,000 colorectal cancer deaths per year by 2030.
Annual FIT IDs all colorectal cancer, and may be equivalent to colonoscopy in detecting advanced neoplasia in first-degree relatives of patients with colorectal cancer (CRC).
A retrospective study has uncovered an overuse of colonoscopies for colorectal cancer screening and surveillance.
For the group deemed at high risk of developing colorectal cancer, fecal blood tests appear to be a more effective means of screening than colonoscopy.
Introducing biennial colorectal cancer screening in a region of France increased the rate of diagnosis of high-risk precancerous adenomas by 89%.
Successful colonoscopy is closely dependent on good bowel preparation, and poor bowel prep often leads to missed precancerous lesions.
Screening with flexible sigmoidoscopy resulted in a reduced incidence and rate of death of colorectal cancer, compared with no screening, according to a recent study.
Little benefit seen for repeat colonoscopy within 10 years in patients with no polyps on initial exam.
A colon cancer screening method that uses stool samples won the unanimous backing of a U.S. advisory panel, opening the way for potential regulatory approval.
For patients undergoing colonoscopy, L-menthol sprayed directly onto the colonic mucosa improves the adenoma detection rate, according to a study.
Colon cancer incidence rates have dropped 30% in the United States in the last 10 years among adults 50 years and older, the largest decrease in people older than 65 years.
Colonoscopy quality and safety are comparable for nurse and physician endoscopy trainees, according to a study.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|